<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/css" href="https://imcjms.com/assets/rss.css" ?><rss version="2.0">
<channel>
    <title>IMC Journal of Medical Science</title>
    <link>https://imcjms.com</link>
    <description>Ibrahim Medical College Journal of Medical Science</description>

                        <item>
                <title><![CDATA[Prevalence and incidence of micro- and
macro-vascular complications in a diabetic population of Bangladesh: a
retrospective cohort study]]></title>

                                    <author><![CDATA[M Abu Sayeed]]></author>
                                    <author><![CDATA[Akhter Banu]]></author>
                                    <author><![CDATA[Parvin Akter Khanam]]></author>
                                    <author><![CDATA[Tanjima Begum]]></author>
                
                <link data-url="https://imcjms.com/registration/journal_full_text/391">
    https://imcjms.com/registration/journal_full_text/391
</link>
                <pubDate>Tue, 28 Sep 2021 11:00:24 +0000</pubDate>
                <category><![CDATA[Original Article]]></category>
                <comments><![CDATA[IMC J Med Sci 2022; 16(1): 002]]></comments>
                <description>Abstract
Background and objectives: Diabetes mellitus (DM) is a major health problem in
South Asian Region including Bangladesh. Increasing prevalence of DM is likely
to cause higher morbidity and mortality. The objective of this study was to
find out the prevalence and incidence of diabetic complications in a
Bangladeshi diabetic cohort attending BIRDEM, a largest referral center in
Bangladesh for endocrine and metabolic diseases.
Methodology: The study was conducted in BIRDEM-OPD (outpatient
department) from 1 January to 31 December of 1995 and analyzed the data of
diabetic cases preserved in BIRDEM registry since 1956. Up to 31 December 1985,
the REFERENCE NUMBER (Ref No) of last case was ‘49,510’. Therefore, this retrospective
cohort comprised of all those patients having Ref No 49,510 or less and
attending BIRDEM-OPD for follow-up. In the year 1995, the cohort had follow-up
for at least ten years. The duration of follow-up was 39 years (1956 to
1995).&amp;nbsp; The study also retrieved
follow-up data from the guidebook of each registered diabetic patient. All data
regarding clinical, anthropometric and biochemical investigations preserved in
BIRDEM registry and in the patient&#039;s guidebook were retrieved and analyzed. The
cohort was categorized into three groups (Gr1, 2 and 3) based on follow-up
duration: &amp;gt;15, 10-15 and &amp;lt;10years, respectively.
Results: Micro-vascular complications (retinopathy and
nephropathy) were the highest among both Gr1 with follow-up &amp;gt;15y and Gr2
with follow-up 10-15y. Compared with the Gr2, retinopathy (34.4 vs. 48.5 %: c2 =11.5, p
&amp;lt;0.001) and nephropathy (24.0 vs. 39.2 %: c2 = 15.6,
p&amp;lt;0.001) were significantly higher in the Gr1. In contrast, HTN, skin-lesion
and periodontal diseases were significantly higher in the Gr2 than in Gr1. All
types of complications were found increasing with the duration of follow-up.
For Gr1, the increasing trend of cerebrovascular accident (CVD/ stroke) and CHD
was significant (p&amp;lt;0.01 and p&amp;lt;0.001). Mean blood glucose of study
population revealed moderate to severe hyperglycemia in successive follow-up
visits. The comparison between patients with and without severe hyperglycemia
(2hPG: &amp;lt;10.0 vs. ³10.0 mmol/l) showed very little difference of
complications. The increasing age over 40 years showed significant risk for CHD
and hypertension.
Conclusion: CHD, stroke and PVD were less frequent compared to
those with retinopathy and nephropathy. Compared to microvascular complications
the macrovascular events resulted in either early death or complete disability
to pursue long-term follow-up. The most important and consistent predictors
were female gender and duration of diabetes.
&amp;nbsp;IMC J Med Sci 2022; 16(1): 002.&amp;nbsp;DOI: https://doi.org/10.55010/imcjms.16.002    
*Correspondence: M. Abu Sayeed,
Department of Community Medicine, Ibrahim Medical College, 1/A Ibrahim Sarani,
Segunbagicha, Dhaka-1000. email: sayeed@imc.ac.bd; sayeed1950@gmail.com
&amp;nbsp;
Introduction
It has been proved that maintenance of
normal blood glucose unequivocally reduces mortality from acute events (or
complications) in diabetic population [1,2]. It has also been unanimous among
diabetologists that normoglycemia is always desirable for wellbeing of the
diabetic subjects [1]. The most common chronic complications were the
development of either micro- or macro-vascular complications. The microvascular
lesions encompass retinopathy, nephropathy and neuropathy. The macrovascular
complications are related to atherosclerosis and include mainly coronary artery
disease (CAD), peripheral vascular disease (PVD) and cerebrovascular disease
(CVD or stroke). Three most world famous prospective studies – Diabetes Complication
Control Trial (DCCT) [2], United Kingdom Prospective Diabetes Study (UKPDS) [3]
and Minnesota study [4] concluded that strict monitoring and maintenance of
normal blood glucose certainly prevents microvascular complications. In
contrast, both the studies could not confirm whether and not ‘strict control of
blood glucose’ effectively prevents macrovascular complications and prevents
atherosclerotic mortality [3,5]. However, there have been a very few cohort studies
to assess the diabetes complications in the south-east Asian region. This
cohort study addressed to determine the prevalence and incidence of micro- and
macro-vascular complications in a diabetes population of Bangladesh.
&amp;nbsp;
Study
design
The study basically analyzed
retrospective data of a cohort of diabetic patients who were registered in the
past at Bangladesh Institute of Research and Rehabilitation in Diabetes,
Endocrine and Metabolic Disorders (BIRDEM). BIRDEM is the largest national
referral center for diabetes and endocrine diseases in Bangladesh. BIRDEM
started registration and follow-up of diabetic patients since 28 February 1956.
The diabetic patients from all areas of the country are usually referred to
this center. The patients are registered after confirmation of diagnosis. Once
registered, they get a unique ‘Reference Number’ (Ref No) printed on the
guidebook for follow-up care throughout life. Baseline information of all
registered patients is stored in the center. Follow- up care records are maintained
in the BIRDEM registry and also written in the guidebook of the patient. The
first registration was started on the 28
February 1956 with Ref No 00001.
This study cohort included all
registered diabetic patients from the first Ref No 00001 (28February 1956) to
the last Ref No 49,510 registered on the 31 December 1985. A total of 49,510
diabetic subjects were registered during this period. The selection criteria of
the cohort was, therefore, all diabetes patients registered at BIRDEM during
this period and attending BIDEM-OPD with their guidebooks for regular follow-up
visits. The data collection period was one year, starting from the first
January to the 31December 1995.
Prior to the study, the doctors and
health staff of BIRDEM-OPD were discussed about the study protocol. It was
decided that whoever attends with reference number £49,510 would be received in a special counter designed
for this cohort study (Figure-1). The guide-books were photocopied for
retrieval of data. The BIRDEM history-sheet and guide book were the sources of
data.
&amp;nbsp;
&amp;nbsp;
Figure-1:
Steps for collecting data from the
patient’s guidebook and from the newly generated investigations’ reports. BP –
blood pressure; ECG – electrocardiogram; CCR – creatinine clearance;
GB – guidebook
&amp;nbsp;
The baseline information included
socioeconomic status, smoking habits, and family history of diabetes,
hypertension, coronary heart disease, peripheral vascular disease and foot
ulcer. The clinical and anthropometric examination included age, height, weight
and calculated body mass index. In addition, measurements of blood pressure
(for hypertension), peripheral arterial pulse for peripheral arterial disease
(PAD), peripheral sensation (for neuropathy), electrocardiogram (for CHD),
ophthalmoscopy (for retinopathy) and urinary albumin (for nephropathy) were
taken. Similarly, for the assessment of biochemical risk factors for micro- and
macro-vascular organic lesion some biochemical investigations were also
included. These were plasma glucose, blood lipids, urea, creatinine,
electrolytes and total urinary protein.
The duration of study cohort was 39
years ranged from 1956 to 1995. We categorized the cohort into three groups: Gr1
with &amp;gt;15 years follow-up, Gr2 with 10-15 years and Gr3 with &amp;lt;10 years. Gr3
was included in the study as the reference for comparative analysis between the
recent and the older subjects with varying duration of follow-ups. The
biophysical (BMI, BP, 2hPG) characteristics of the patients with shorter
duration were compared with the longer duration.
Statistical analyses: The prevalence of complications was shown in
percentages. Comparison between groups (men vs. women, rural vs. urban, Gr1 vs.
Gr2) were estimated by unpaired t-test. Chi-sq test was used to determine the
associations between variables. Chi-sq trend test estimated the trend of
complications with increasing duration. The level of significance was accepted
p&amp;lt;0.05. SPSS Window 19.0 Version was used for all these analyses.
&amp;nbsp;
Results
According BIRDEM registry 26,349 diabetic
patients were registered up to 31 December 1980. This was Gr1 cohort. Of the
total 26,349, only 171 (0.7%) were found attending BIRDEM-OPD for follow up.
The baseline and follow up data (complications, hospitalization and other
investigations) of these 171 patents were retrieved either from their
guidebooks or from the BIRDEM registry. The Gr2 cohort comprised 23,161
patients registered from 1 January 1981 to 31 December 1985. Of them, 625 (2.7%)
were found attending BIRDEM-OPD for follow up. The Gr3 consisted of only 110
diabetic patients, supposedly, with fewer complications. They were registered
from January 1986 through December 1990. The socio-demographic characteristics
of Gr1 and Gr2 are shown in Table-1 and 2. The tables also depicted the number
of patents attended follow up in successive 5 years interval. Both the groups
showed urban predominance than the rural plus suburban. The predominance of female
was found in Gr2 but of male in Gr1.
&amp;nbsp;
Table-1: Area and sex
distribution of the study population, registered up to December 1980 (Gr1), and
according to successive 5-year follow-up (n = 171).
&amp;nbsp;
&amp;nbsp;
Table-2: Area and sex
distribution of the study population, registered from Jan 1981 through December
1985 (Gr2), and according to successive 5-year follow-up (n = 625).
&amp;nbsp;
&amp;nbsp;
Table-3: Mean
post-prandial plasma glucose level of study population observed at registration
and in the successive 5-year follow-up for ³15-year
follow-up study (male + female, n=171, Gr1).
&amp;nbsp;
&amp;nbsp;
Table-4: Comparison of
mean post-prandial plasma glucose level of the study population observed
between at registration and last 5-year follow-up period for male and female 
&amp;nbsp;
&amp;nbsp;
Table-5: The prevalence
of macrovascular complications among the diabetic patients (n=171) who had ³15 years follow-up. 
&amp;nbsp;
&amp;nbsp;
Table-6: The prevalence
of microvascular complications among the diabetic patients (n=171, older group)
who had ³15 years
follow-up at BIRDEM-OPD. 
&amp;nbsp;
&amp;nbsp;
The trend of 2h post-prandial glucose (2hBG)
level of Gr1 is shown at registration and in the subsequent 5 year follow-up
period in Table-3. The values of 2hBG were increasing significantly in every 5
years. This indicated that glycemic control target (≤7.8mmol/l) could not be
maintained over the years. The significant increasing trend was observed in both
male and female cases (Table-4).
</description>

            </item>
            
    <copyright>2026 Ibrahim Medical College. All rights reserved.</copyright>
</channel>
</rss>
